PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED
on 25 Oct 2024
Last Applicant/ Owned by
22 Boulevard Benoni Gouillin
Nantes
FR
44200
Serial Number
86942598 filed on 16th Mar 2016
Registration Number
5320086 registered on 31st Oct 2017
Correspondent Address
Patrick J. Jennings
Filing Basis
No Filing Basis
Disclaimer
NO DATA
OSE IMMUNOTHERAPEUTICS
[ Scientific and technological services, namely, research and design services in the fields of cancer treatment, oncology, immunotherapy; design and development of software and databases; medical research; biological and biotechnology research; pharmaceutical research; conducting clinical studies for others ] [ Medical services ] Pharmaceutical products [ in the nature of chemicals ] for cancer Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
[ Medical services ]
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
[ Scientific and technological services, namely, research and design services in the fields of cancer treatment, oncology, immunotherapy; design and development of software and databases; medical research; biological and biotechnology research; pharmaceutical research; conducting clinical studies for others ]
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical products [ in the nature of chemicals ] for cancer treatment, oncology and immunotherapy; [ sanitary preparations for medical purposes; ] pharmaceutical products for human medicine for cancer treatment, oncology and immunotherapy; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy [ for auto immune diseases and biological tissue grafts or skin grafts; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Substances for medicinal use, namely, synthetic peptides for cancer treatment, oncology and immunotherapy, adjuvants for medical purposes, stem cells for medical purposes; Vaccines for treating cancer; vaccines; Substances for medicinal use, namely, serums for cancer treatment, oncology and immunotherapy, monoclonal antibodies for cancers, auto immune diseases and biological tissue grafts or skin grafts; Pharmaceutical products, namely, targeted therapies for cancers, auto immune diseases and biological tissue grafts or skin grafts ]
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 86942598
Mark Type
No Service Mark
Attorney Docket Number
No 22044-446388
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 25th Oct 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 25th Oct 2024 | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 25th Oct 2024 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| 23rd Oct 2024 | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 |
| 23rd Oct 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 30th Apr 2024 | TEAS SECTION 8 & 15 RECEIVED |
| 31st Oct 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 31st Oct 2017 | REGISTERED-PRINCIPAL REGISTER |
| 15th Aug 2017 | PUBLISHED FOR OPPOSITION |
| 15th Aug 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |